The urethra is the tube from the bladder through which urine exits the body. Urethral cancer occurs when malignant cells form in the tissues of the urethra.
It is a relatively rare disease and tends to occur more often in women than men. There are several types of urethral cancer, based on the location in the urethra where it forms (different areas have different cell types). Patients with a history of bladder cancer or chronic inflammation (urinary tract infection or sexually transmitted diseases) may be more prone to develop cancer of the urethra.
Signs and symptoms may include bleeding or discharge from the urethra (or blood in the urine), slow, interrupted, or frequent urination, or a lump or thickness in the perineum or penis.
A diagnosis may be suspected based on history and physical examination and may require urine tests, investigation with cystoscopy and biopsy, and imaging studies (like ultrasound, CT scan, or MRI).
Treatment varies depending on the stage of the disease but may include surgery, chemotherapy or radiation. We employ a multidisciplinary approach, with urologists, medical oncologists, radiation oncologists, pathologists, radiologists, and clinical trial specialists to determine the full spectrum of treatment options available and most suitable for an individual patient.